Patent · US Active

Bruton's tyrosine kinase inhibitors

US9790229B2 · kind B2 · utility

7Cited by
14References
21Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJan 25, 2016
Grant dateOct 17, 2017
Priority date
Expiry dateJan 25, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/519
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compounds useful as inhibitors of Btk, compositions thereof, and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.